Cancer stem cells were first convincingly demonstrated in AML, where a slow-cycling primitive hematopoietic cell proved to be responsible for the hierarchical organization observed in a heterogeneous cancer cell population143, and subsequently also in solid tumors, where breast-cancer cells expressing CD44+/CD24– were shown to be capable of initiating a new tumor in immunodeficient mice144. This evidence concerns the gene CD44 and cancer.